Insider Transactions in Q2 2025 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2025
|
Kevin Mc Culloch Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+1.44%
|
$100,000
$4.38 P/Share
|
|
Jun 04
2025
|
Marla Persky Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+24.1%
|
-
|
|
Jun 04
2025
|
Barbara Jean Anne Bormann Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+24.1%
|
-
|
|
Jun 04
2025
|
John Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.05%
|
-
|
|
Jun 04
2025
|
Jeffrey W Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+18.91%
|
-
|
|
Jun 04
2025
|
Dawn Halkuff Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+24.1%
|
-
|
|
Jun 04
2025
|
Garheng Kong Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+18.93%
|
-
|
|
Apr 02
2025
|
Kevin Mc Culloch Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-0.04%
|
$3,665
$5.15 P/Share
|